Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Molecular distinction between muscarinic acetylcholine receptor subtypes


The muscarinic acetylcholine receptor (mAChR) mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels, through the action of guanine nucleotide-binding regulatory proteins1–3. Pharmacologically distinguishable forms of the mAChR occur in different tissues and have provisionally been classified into M1 (I), M2 cardiac (II) and M2 glandular (III) subtypes on the basis of their difference in apparent affinity for antagonists4–8. In an attempt to elucidate the molecular basis of the functional heterogeneity of the mAChR, we have cloned and sequenced DNAs complementary to porcine cerebral and cardiac messenger RNAs encoding mAChRs and have thereby deduced the primary structures of the receptor proteins9,10. We report here that the messenger RNA generated by transcription of the cardiac complementary DNA directs the formation of a functional mAChR in Xenopus oocytes and that this mAChR differs from the mAChR formed by expression of the cerebral cDNA9 both in acetylcholine (ACh)-induced response and in antagonist binding properties. Our results provide evidence indicating that the mAChR encoded by the cerebral cDNA (designated as mAChR I) and the mAChR encoded by the cardiac cDNA (mAChR II) are of the M1 (I) and the M2 cardiac (II) subtype, respectively.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout


  1. 1. Burgen, A. S. V. Trends pharmac. Sci. Suppi 5, 1–3 (1984). 2. Brown, D. Nature 319, 358–359 (1986). 3. Oilman, A. G. Trends Neurosci. 9, 460–463 (1986). 4. Hammer, R., Berrie, C. P., Birdsall, N. J. M., Burgen, A. S. V. & Hulme, E. C. Nature 283, 90–92 (1980). 5. Birdsall, N. J. M. & Hulme, E. C. Trends pharmac. Sci. 4, 459–463 (1983). 6. Hammer, R., Giraldo, E., Schiavi, G. B., Monferini, E. & Ladinsky, H. Life Sci. 38,1653–1662 (1986). 7. Watson, M. et al. Trends pharmac. Sci. Suppl. 7, 46–55 (1986). 8. Birdsall, N. J. M. et al. Biochem. Soc. Symp. 52, 23–32 (1986). 9. Kubo, T. et al. Nature 323, 411–416 (1986). 10. Kubo, T. et al. FEBS Lett. 209, 367–372 (1986). 11. Melton, D. A. et al. Nucleic Acids Res. 12, 7035–7056 (1984). 12. Barish, M. E. / Physiol., Land. 342, 309–325 (1983). 13. Miledi, R. & Parker, I. /. Physiol., Lond. 357, 173–183 (1984). 14. Dascal, N., Gillo, B. & Lass, Y. /. Physiol., Lond. 366, 299–313 (1985). 15. Kusano, K., Miledi, R. & Stinnakre, J. / Physiol., Lond. 328, 143–170 (1982). 16. Dascal, N., Landau, E. M. & Lass, Y. / Physiol, Lond. 352, 551–574 (1984). 17. Berrie, C. P., Birdsall, N. J. M., Burgen, A. S. V. & Hulme, E. C. Br. J. Pharmac. Suppl. 78, P67 (1983). 18. Watson, M., Roeske, W. R. & Yamamura, H. I. /. Pharmac. exp. Ther. 237, 419–428 (1986). 19. Hammer, R., Giachetti, A. Life Sci. 31, 2991–2998 (1982). 20. Schimerlik, M. I., Miller, S., Peterson, G. L., Rosenbaum, L. C. & Tota, M. R. Trends pharmac. Sci. Suppl. 7, 2–7 (1986). 21. Cheng, Y.–C. & Prusoff, W. H. Biochem. Pharmac. 22, 3099–3108 (1973). 22. Sugiyama, H., Hisanaga, Y. & Hirono, C. Brain Res. 338, 346–350 (1985). 23. Konarska, M. M., Padgett, R. A. & Sharp, P. A. Cell 38, 731–736 (1984). 24. Sakmann, B. et al. Nature 318, 538–543 (1985).

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fukuda, K., Kubo, T., Akiba, I. et al. Molecular distinction between muscarinic acetylcholine receptor subtypes. Nature 327, 623–625 (1987).

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI:

This article is cited by


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing